HIV coinfection with hepatitis c epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
m (Changes made per Mahshid's request)
 
(One intermediate revision by one other user not shown)
Line 15: Line 15:
{{Reflist|2}}
{{Reflist|2}}
[[Category:Needs content]]
[[Category:Needs content]]
[[Category:Hepatitis|C]]
[[Category:Gastroenterology]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Gastroenterology]]
[[Category:Needs overview]]
[[Category:Needs overview]]

Latest revision as of 18:01, 18 September 2017

HIV coinfection with hepatitis c Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Differentiating HIV coinfection with hepatitis c from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

HIV coinfection with hepatitis c epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of HIV coinfection with hepatitis c epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on HIV coinfection with hepatitis c epidemiology and demographics

CDC on HIV coinfection with hepatitis c epidemiology and demographics

HIV coinfection with hepatitis c epidemiology and demographics in the news

Blogs on HIV coinfection with hepatitis c epidemiology and demographics

Directions to Hospitals Treating HIV coinfection with hepatitis c

Risk calculators and risk factors for HIV coinfection with hepatitis c epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Epidemiology

The majority of coinfected people are injection drug user (IDUs). HCV is acquired relatively soon after individuals begin injecting drugs. Within 5 years of beginning to inject, 50% to 80% of IDUs are infected with HCV. As a result, many IDUs who become infected with HIV are already infected with HCV. It is estimated that 50% to 90% of IDUs with HIV also have HCV .

Between 1996 and 2000, more than 80% of the patients admitted to a large HIV/AIDS care center in Madrid, Spain, were IDUs. The proportion of these patients who were admitted because of liver failure almost doubled, from 9% to 16%.

Prevalence

About one-third of people with HIV are coinfected with hepatitis B virus (HBV) or hepatitis C virus (HCV), with a considerably higher prevalence among injection-drug users.

References